Form EFFECT Galmed Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 3, 2026 |
| Accession Number: | 0001493152-26-041245 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering
- Luxury Air A/C & Heating Celebrates 18 Years of Serving Texas Homeowners
- Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
